- Home
- REAL vs ENGN Comparison
REAL vs ENGN Comparison
Compare REAL & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- ENGN
- Stock Information
- Founded
- REAL 2011
- ENGN 1999
- Country
- REAL United States
- ENGN Canada
- Employees
- REAL N/A
- ENGN N/A
- Industry
- REAL Other Specialty Stores
- ENGN
- Sector
- REAL Consumer Discretionary
- ENGN
- Exchange
- REAL Nasdaq
- ENGN Nasdaq
- Market Cap
- REAL 982.8M
- ENGN 293.1M
- IPO Year
- REAL 2019
- ENGN N/A
- Fundamental
- Price
- REAL $9.33
- ENGN $7.50
- Analyst Decision
- REAL Buy
- ENGN Strong Buy
- Analyst Count
- REAL 6
- ENGN 8
- Target Price
- REAL $5.96
- ENGN $30.38
- AVG Volume (30 Days)
- REAL 3.5M
- ENGN 144.6K
- Earning Date
- REAL 11-04-2024
- ENGN 01-27-2025
- Dividend Yield
- REAL N/A
- ENGN N/A
- EPS Growth
- REAL N/A
- ENGN N/A
- EPS
- REAL N/A
- ENGN N/A
- Revenue
- REAL $579,862,000.00
- ENGN N/A
- Revenue This Year
- REAL $11.29
- ENGN N/A
- Revenue Next Year
- REAL $8.00
- ENGN N/A
- P/E Ratio
- REAL N/A
- ENGN N/A
- Revenue Growth
- REAL 2.52
- ENGN N/A
- 52 Week Low
- REAL $1.52
- ENGN $4.42
- 52 Week High
- REAL $9.74
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- REAL 94.33
- ENGN 38.55
- Support Level
- REAL $5.70
- ENGN $8.00
- Resistance Level
- REAL $9.29
- ENGN $8.89
- Average True Range (ATR)
- REAL 0.54
- ENGN 0.61
- MACD
- REAL 0.39
- ENGN -0.07
- Stochastic Oscillator
- REAL 92.70
- ENGN 3.00
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.